×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: savaysa | blood | thinner | drug

New Blood Thinner OKd by FDA

Friday, 09 January 2015 09:18 AM

U.S. regulators on Thursday approved the use of a drug made by Daiichi Sankyo to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem.

The new drug, Savaysa, will compete with older blood thinners, including Xarelto, sold by Bayer and Johnson & Johnson, Boehringer Ingelheim's Pradaxa, and Bristol-Myers Squibb's Eliquis.

The Food and Drug Administration said the Daiichi drug is also approved to treat deep vein thrombosis and pulmonary embolism in patients who have already been treated with an anti-clotting drug administered by injection or infusion, for five to ten days.

The agency said that, as with other approved anti-clotting drugs, bleeding, including life-threatening bleeding, is the most serious risk with Savaysa.

Atrial fibrillation affects about 3 million Americans, causing blood to pool in a storage chamber of the heart, where it can clot and travel to the brain.

© 2022 Thomson/Reuters. All rights reserved.


Health-News
U.S.regulators on Thursday approved the use of a drug made by Daiichi Sankyo to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem.The new drug, Savaysa, will compete with older blood thinners, including...
savaysa, blood, thinner, drug
151
2015-18-09
Friday, 09 January 2015 09:18 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved